Marianna Baum
Bio
Dr. Marianna K. Baum, Ph.D., RD, serves as the Distinguished University Professor at the Robert Stempel College of Public Health and Social Work, Florida International University in Miami, Florida. Dr. Baum is a highly recognized researcher nationally and internationally in HIV and metabolism. Her research focuses on middle-aged and older adults living with and without HIV and with and without substance abuse. She is studying the effect on cognition, frailty, immunity, comorbidities, including obesity, heart disease, diabetes, and cancer. Most recently, she is also investigating longitudinally the epigenetic modifications of cognitive frailty, epigenetic changes in hypertension and inflammation. She is also investigating whether epigenetic cognitive frailty signatures predict structural and functional neuroimaging patterns and whether neuroimaging patterns can predict neurocognitive and physical components of cognitive frailty over time. Lastly, she is leveraging existing relationships with end-users to bridge research and practice, and inform decisions and implement linkages to HIV and substance use services and detection and treatment of functional and cognitive comorbidities.
Publications
Burke, S. L., Grudzien, A., Li, T., Garcia, S., Sales Martinez, S., Jurich, E., Jimenez, D.R., Hernandez, J., Liu, Q., Tyrell, T. A., Goulett, N., Campa, A. L., Bursac, Z. & Baum, M.K. (In press). The influence of socioeconomic factors on the correlation between apolipoprotein E genotype and cognitive outcomes in a multi-ethnic sample living with HCV and HIV. International Journal of STD & AIDs, February 2025.Bradley H, Luisi N, Carter A, Pigott TD, Baum M, et al. Assessing COVID-19 pandemic impacts on the health of PWID using a novel data sharing model" AIDS. 2024 November 28, 2024. doi: 10.1097/QAD.0000000000004076.
Burke, S. L., Grudzien, A., Li, T., Garcia, S., Sales Martinez, S., Jurich, E., Jimenez, D.J., Hernandez, J., Liu, Q., Tyrell, T. A., Campa, A. L., Johnson, A., Bursac, Z., Baum, M.K. Substance use moderates relationships between apolipoprotein E genotype, hepatitis C, cognition, and depression in Miami Adult Studies on HIV (MASH) participants. Journal of NeuroVirology, 2024 Aug 12. doi: 10.1007/s13365-024-01225-8.
Tamargo JA, Martin HR, Diaz-Martinez J, Delgado-Enciso I, Johnson A, Bastida Rodriguez JA, Trepka MJ, Brown DR, Garba NA, Roldan EO, Hernandez Suarez Y, Marty AM, Bursac Z, Campa A, Baum MK. Drug use and COVID-19 testing, vaccination, and infection among underserved, minority communities in Miami, Florida. PLoS One. 2024 Apr 30;19(4):e0297327. doi: 10.1371/journal.pone.0297327.
Martin H, Brown D, Fluney E, Trepka M, Marty A, Roldan E, Liu Q, Barbieri M, Baum, M. Community-Engaged Research: COVID-19 Testing, Infection, and Vaccination among Underserved Minority Communities in Miami, Florida. Vaccines (Basel). 2024 Jan 24;12(2):117. doi: 10.3390/vaccines12020117.3.
Sneij A, Campa A, Huffman FG, George F, Sales Martinez S, Baum M. Improved vitamin C intake in people living with HIV and prediabetes after 6-months nutrition intervention: A randomized, controlled trial. J Acad Nutr Diet. Oct 2023, 123(10):A20 DOI: https://doi.org/10.1016/j.jand.2023.08.045
Martin HR; Hu N, Liu Q, Bastida Rodriguez JA, Gieseken S, Johnson A, Enrione W, Trepka MJ, Brown DR, Marty AM, Sales Martinez S, Campa A, Roldan EO, Hernandez Suarez Y, Barbieri M, Palacios C, Bursac Z, Baum MK. Disability and COVID-19: Challenges, testing, vaccination, and postponement and avoidance of medical care among minoritized communities. Disability & Health J. 2023 Dec 8:101571. doi: 10.1016/j.dhjo.2023.101571
D'Agostino EM, Ramirez Garcia J, Bakken SR, Wruck L, Nilles EK, Stefano TA, Martin HR, Hungler S, Lee RE, Perreira KM, Baum MK, Brown D. Examining COVID-19 testing and vaccination behaviors by heritage and linguistic preferences among Hispanic, Latino, or Spanish RADx-UP participants. Prev Med Rep. 2023;35:102359. Published 2023 Aug 2. doi:10.1016/j.pmedr.2023.102359
Clarke R, Garba N, Barbieri M, Acuna L, Baum MK, Stefano T, Mathee K, Narasimhan G, Saad Rodriguez M, Frias H, Saldarriaga P, Brown D. Detection of SARS-CoV-2 in High-Efficiency Particulate Air (HEPA) Filters of Low-Cost Air Purifiers in Community-Based Organizations", Environmental Monitoring and Assessment, Environ Monit Assess. 2023 Oct 14;195(11):1320. doi: 10.1007/s10661-023-11950-y.
Martin HR, Sales Martinez S, Stebliankin V, Tamargo JA, Campa A, Narasimhan G, Hernandez J, Bastida Rodriguez JA, Teeman C, Johnson A, Sherman KE, Baum MK. Diet quality and liver health in people living with HIV in the MASH cohort: A multi-omic analysis of the fecal microbiome and metabolome. Metabolites. 2023 Feb 14;13(2):271. doi: 10.3390/metabo13020271.
Javanbakht M, Khan L, Mustanski B, Shoptaw S, Baum M, Mehta S, Kirk G, Lai S, Moore R, Milloy M-J, Kipke M, Hayashi K, DeBeck K, Siminski S, White L, Gorbach P, Substance use and other factors associated with COVID-19 vaccine uptake among people at risk for or living with HIV: Findings from the C3PNO Consortium.. Prev Med Rep. 2023 Jun 24;35:102300. doi: 10.1016/j.pmedr.2023.102300.
Ongoing and completed research support (2015-2025)
2022-2025 Principal Investigator, NIH/NIMHD: #1U01MD017423-01 “Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations Phase II” $2,211,124.
2020-2023 Principal Investigator, NIH/NIDA: #3U01DA040381-05S1 “Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations” $ 4,023,864.
2015-2023 Principal Investigator, NIH/NIDA: Cohort Studies on HIV/AIDS and Substance Abuse in Miami. #1U01DA040381, $8,627,877.
2016-2023 Consortium Principal Investigator, NIH/NIDA: OMICs to define impact of cocaine on immunity and liver disease in HIV infection. #5R01DA042712, $1,112,362.
2016-2023 Consortium Principal Investigator, NIH/NIDA: An Unbiased OMICs Approach to Identify Mechanisms of Cocaine Regulation of the HIV Reservoir. #5R01DA043263, $1,510,630.
5017-2018 Principal Investigator, NIH/NIDA: Cohort Studies on HIV/AIDS and Substance Abuse in Miami. Administrative Supplement #3 U01 DA040381-02S1. $766,800.